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Maryland
Variations in the frequency of analgesic nephro-
pathy within Britain. British physicians were slow to
appreciate the existence of analgesic-induced renal
disease, and the first case was not recorded until
1964 [1]. Thereafter, although the disorder was
increasingly recognized in Britain, there was a strik-
ing variation in the geographic distribution of the
cases reported. By 1972, a total of 225 cases had
been reported [2—191; 169 of these had come from
Scotland [13—191, with 70% from the Glasgow area
[16—191. In an effort to establish whether this was a
true reflection of the prevalence of the condition, or
an aberration due to the interest of Scottish physi-
cians in it, I sent a questionnaire to the major renal
units throughout Britain regarding their experience
of analgesic nephropathy. The replies demonstrated
that there was considerable variation, with the few-
est cases seen in the Midlands and North-West
England, more in Newcastle and London, but most
in Glasgow (Fig. 1) [20].
Confirmation of this came from two other sources.
In 1970, Kontsaimanis and de Wardener [10] esti-
mated that the annual incidence of new cases in
England and Wales was at least 450; this was based
on the number of new cases referred to Charing
Cross Hospital each year. A similar calculation
based on new cases seen at Western Infirmary, Glas-
gow, produced an incidence four times the English
one. This increased frequency in the Glasgow area
does not seem to hold for the rest of Scotland. While
25.5% of patients admitted to the renal unit of the
Western Infirmary with chronic renal failure had
analgesic nephropathy, a survey by Pendreigh et a!
[211 revealed that analgesic nephropathy accounted
for only 4.8% of all cases of end-stage renal failure in
Scottish adults.
A second part of my survey concerned the analge-
sics implicated in causing the renal damage. In spite
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of the large number of analgesics available, only six
preparations (all compound analgesics) were incrimi-
nated by more than one unit. The preparations
blamed most often varied throughout the country,
and clearly paralleled the regional analgesic prefer-
ences of the general population established in a sur-
vey by National Opinion Polls [22]. Scots, in gener-
al, do not consume more analgesics than other
Britons [22], and the per capita consumption of
phenacetin in Soctland is similar to that in England
and Wales [10, 231. I therefore concluded that the
reason why analgesic nephropathy is more common
in Western Scotland must lie either with the particu-
lar preparations taken or the manner in which they
are consumed.
Use and abuse of analgesics by different popula-
tion within Glasgow. In Western Scotland, three
quarters of cases of analgesic nephropathy result
from a compound analgesic powder called Askit®
[181, this formerly contained aspirin, phenacetin,
and caffeine, but the phenacetin has now been with-
drawn. Askit is manufactured in Glasgow, and 95%
of their sales are in Scotland. Since there was no
evidence that they were more nephrotoxic than other
analgesics, I decided to examine the possibility that
they were more habit-forming. The analgesic habits
of two different populations were studied. The first
was a series of 211 patients admitted to a medical
unit of a Glasgow hospital. The results [24] demon-
strated a clear relation between the frequency of
analgesic ingestion and the preparation taken. Aspi-
rin was the most popular preparation among patients
who rarely took analgesics, but its popularity
declined among those taking analgesics daily without
medical advice. On the other hand, Askit® (which
had 22% of the Scottish market) was taken by only
17 out of the 104 who took analgesics less than
weekly, but it was taken by 10 of the 21 who took
daily analgesics without medical advice; this differ-
ence was statistically significant (X2 = 10.3; P <
0.01).
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Fig. 1. Geographic distribution of analgesic nephropathy cases reported within Britain. The
number of cases seen per year are shown in brackets. Abbreviations used are A.P.C. =
aspirin, phenacetin, caffeine; An = Anadin; Ask = Askit; Be = Beechams; Cod = Tabs.
Codeine Co. or Veganin; Phen = Phensic. (Reprinted from Health Bulletin [20] by permission
of the Controller, Her Majesty's Stationery Office.)
The patients were also asked about various indica-
tions for taking analgesics and which preparation
would be most effective for different indications (Fig.
2). Most believed that the drugs would be of value for
headaches (91%), colds (79%), pain (68%), and peri-
od pains (69%). A smaller proportion thought they
would be helpful for nerve pains (48%), as a sedative
(35%), and a hypnotic (32%), and fewer still as a
stimulant (18%). Different drugs were valued for
different symptoms. Aspirin and paracetomol were
considered most useful for pain and headache, while
codeine compound (aspirin, phenacetin, and cod-
eine) was the preparation of choice for insomnia;
Askit®, only one third as popular as aspirin for pain,
was the most valued drug for nerve pains, period
pains, sedation, and stimulation. Thus, the two prep-
arations most associated with analgesic nephropathy
in Britain (Askit® and compound codeine [201) were
particularly valued for inappropriate reasons.
This study and a subsequent community survey of
740 Glasgow citizens [251 demonstrated that those
taking regular prescribed analgesics and those on
daily self-medication formed two distinct groups:
most of the former were over 60 years old, the sex
distribution was almost equal, and all had an organic
reason for taking the drugs. On the other hand, daily
analgesic self-medication was most common in wom-
en in their thirties and forties who belonged to the
lower social classes. These self-medicators were
more likely to take Askit® powders than other prepa-
rations, and rarely had organic pain. Comparing
medical patients who provided themselves daily
analgesics with those who took them less than week-
ly revealed that the former were significantly more
likely to have seen a psychiatrist (X2 = 9.1; P <
0.01).
An obvious step was to compare the frequency of
analgesic-taking among these two groups with that of
psychiatric patients. A survey of patients admitted to
a local psychiatric hospital had been previously car-
ried out [17]. Whereas only 5% of the general public
and 17% of medical patients admitted taking daily
analgesics, 23% of the psychiatric patients did so.
The latter were almost exclusively taking the drugs
for nonorganic reasons, and their psychiatrists were
only rarely aware of the analgesic consumption;
women with reactive depression, chronic neurosis,
and inadequate personality appeared especially
prone to take large amounts. Further enquiry in that
hospital revealed that the staff were aware of 22
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Fig. 2. Reasons jhr taking anolgesics and preference of preparation reported by patients in
Glasgow.
other patients who had abused analgesics. The blood
urea concentration was known to have been elevated
in 14 of their patients, and four had died in chronic
renal failure. Eight had undergone gastric surgery,
and a further seven had been investigated for gas-
trointestinal bleeding or peptic ulceration.
A psychosocial study of patients with analgesic
nephropathy
Many physicians [13, 20—281 have noted that their
patients with analgesic nephropathy seldom had an
organic reason for taking the drugs, and have com-
mented on the frequency of psychiatric disorder [25,
27, 29—311. But, in spite of the vast number of
reports of analgesic nephropathy, there had been
little research into its psychological and social
origins. I, therefore, determined to carry out such an
investigation [32, 331.
The study included all patients with analgesic
nephropathy attending the renal unit of the Western
Infirmary, Glasgow, between 1969 and 1971. For
such a diagnosis, three conditions had to be met: 1)
The ingestion of at least one gram of analgesic daily
for three years and the total consumption of a mini-
mum of 3 kg of aspirin or phenacetin, 2) the exclu-
sion of any other cause of renal disease, 3) creatinine
clearance of 75 ml/min or less.
During the three-year period, 51 patients met these
criteria. A detailed psychological and social history
was obtained from these 51 patients, and information
regarding demographic details, analgesic habits,
medical and psychiatric history, and personal and
family history was recorded in a standardized form.
Wherever possible, relatives were also interviewed,
and case histories from other hospitals were
scrutinized.
For the purposes of analysis of these data, the
patients were compared with 51 controls who were
interviewed in a similar fashion. These were selected
from over 300 consecutive medical admissions on the
basis that they matched the patients for age and sex
and did not take daily analgesics.
The ages of the 51 patients ranged from 27 to 72,
with a mean SD of 52.2 10.5 yr, and females
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predominated over males in the ratio of 4.1 to 1. Men
presented at a significantly older age (t = 2.32; P <
0.0125) than women (mean ages, 58.9 and 50.6 yr,
respectively).
Renal papillary necrosis was demonstrated radio-
logically or histologically in 37 patients, and the clini-
cal picture in the remaining 14 was typical of analge-
sic-induced renal disease. There were 20 patients
with hypertension, and the average creatinine clear-
ance was 26 milmin. Nine had undergone gastric
surgery, and 27 were anemic. These physical fea-
tures have been described in detail elsewhere [18,
34].
Analgesic habits. Forty-five of the patients were
taking either Askit® powders or compound codeine
tablets. Apart from one patient who took simple
aspirin, all the rest had taken preparations which
contained at least two analgesics (usually aspirin and
phenacetin) plus at least one other centrally acting
drug (codeine, caffeine, or bromide). Women were
significantly more likely (X2 = 4.6; P <0.05) to take
Askit® than men (31 out of 41, compared with 4 out
of 10).
The intake the patients admitted varied from two
to more than 15 preparations daily, and the duration
of ingestion from 4 to 45 years (average of six daily
for 20 years). Thirty-one patients had begun their
analgesic consumption before 30, and 16 before 20
years of age. The approximate total dose admitted
ranged from 4 kg of aspirin and 3 kg of phenacetin to
69 kg of aspirin and 51 kg of phenacetin (average of
19 kg of aspirin and 14 kg of phenacetin).
Stated reasons for analgesic taking. Twenty-four
patients recognized that they took the analgesics
believing that they had mood-altering properties. Six
patients believed that they were stimulating—"they
give me a lift"—while nine took them for sedation.
Four patients thought the drugs had both these quali-
ties—"Codeine perked me up and made me cal-
mer' '—while a further five were unable to exactly
describe their reason—"an Askit is heaven, Doc-
tor." Sedative or stimulating properties were not
particularly attributed to any one preparation.
Twenty-two patients claimed that they took the
analgesics for headaches. These were usually
described as being like a pressure or vague fullness
and were often precipitated by emotional stress.
Some of these patients realized that the analgesics
not only relieved their pain but also gave them a
feeling of wellbeing. Only two had an organic reason
for taking the drugs (arthritis), and both of these also
benefitted psychologically.
In all, 39 patients believed that their analgesic
ingestion had "become a habit," while 12 maintained
that they only took the drugs for pain. Most patients
had absolute faith in the efficacy of their favorite
preparation, and would go to great lengths to obtain
it. One chemist stated that, when supplies of a
patient's favorite powder ran out "she would get like
a wreck," while one man described his wife as "like
a mad thing without a Beechams."
Reluctance to admit analgesic-taking. Few
patients volunteered information about their analge-
sic habits, and 19 denied analgesic consumption—in
some cases even after analgesic nephropathy had
been proven radiologically. Patients universally min-
imized the extent and duration of their analgesic
intake. Although in a few cases analgesic taking had
been concealed even from spouses, relatives' esti-
mates of the analgesic intake were usually more
accurate and were often three or four times higher
than the patients' estimates. This reluctance to admit
analgesic ingestion had often led to misdiagnosis.
Patients had commonly been investigated for renal
disease, anemia, and peptic ulcer. Seldom, however,
had the history of analgesic ingestion been elicited;
its causative role had not been appreciated, and renal
function had continued to deteriorate.
At least 31 patients had continued their analgesic
habit against family opposition. In some cases the
family had hidden or destroyed the analgesics, and in
a few the patients were not given sufficient money to
buy the drugs. Family opinions ranged from "she
seems to need them" to "she's an addict" or "she's
doped silly with Askit."
None of the patients obtained their drugs on pre-
scription, and few of their doctors were aware of the
abuse. The analgesics were usually bought in gro-
cers' or corner shops rather than chemists' shops.
Some shopkeepers continued supplying the drugs
although they realized the patients were habituated,
but others had refused the patients further analge-
sics. To circumvent this, some patients sent relatives
or children to get them.
Social characteristics. All the patients were Scot-
tish, and their religious persuasion and civil status
did not differ from that of the controls or the general
population. Both patients and controls were predom-
inantly from the lower social classes, but significant-
ly more of the patients had ceased their education at
the minimum school-leaving age (X2 = 4.05; P <
0.05).
Only 15 patients were working; 21 women had
stopped working for normal social reasons, five
because of psychiatric and two because of physical
illness. Of the ten men, three had retired, four were
incapable of working because of psychiatric abnor-
mality, and one because of physical illness. None of
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the patients had a profession. The women had
worked mainly as shop assistants, office, and factory
workers, while the men's occupations simply reflect-
ed the local patterns of employment. The totally
unskilled were less likely to he working (X2 = 6.8; P
<0.01).
Family history. Patients were much more likely
than controls (X2 = 14.7; P <0.001) to give a history
that another member of the family had abused anal-
gesics. Twenty-two patients gave such a history, and
in six cases more than one relative was said to have
abused the drugs. Of the 29 affected relatives, 11
were the mothers and five the sisters of the patients,
and 11 were known to have analgesic-induced
disease.
Patients were also much more likely (X2 = 16.7; P
<0.001) to volunteer that a relative abused alcohol.
This was particularly common among the families of
women patients, 21 of whom gave such a history
compared with only one man (X2 = 5.6; P <0.05).
In 18 cases, the relative's history was suggestive of
alcoholism, and in four of a severe alcohol problem;
fathers and husbands were especially affected.
A family history of psychiatric disorder was
obtained from 20 patients but only five controls; this
difference, too, is highly significant (X2 = 11.9; P <
0.001). Although the exact diagnosis could seldom be
established, 26 relatives were affected and four had
committed suicide.
Personal history. Patients were much more likely
than controls to have had previous psychiatric treat-
ment (X2 = 18.8; P <0.001); 11 had had outpatient
and 12 in-patient treatment, and 2 were long-term in-
patients. Neurotic and depressive reactions, person-
ality disorder, and anxiety states were the main diag-
noses that had been ascribed to them. Three had
been treated for alcoholism or drug addiction.
All but five of the remainder had attended their
own doctors for nervous disorder, and only two were
psychologically normal. Again, neuroses and person-
ality disorder of an inadequate nature were the rule.
Two-thirds had chronic insomnia, and seven had
previously attempted suicide. There was no relation
between the severity of physical disease and psychi-
atric morbidity.
Psychotropic drugs had been taken in the previous
three years by 47 of the patients, compared with only
14 of the controls; this difference is highly significant
(X2 = 41; P <0.001). The majority had been taking
hypnotics, but 35 had also received tranquillizers,
and 12, antidepressants. Six patients had abused
tranquillizers; four, alcohol; two, amphetamines; and
2, opiates.
Daily purgative-taking was much more common
among the patients than the controls (X2 = 11.9; P <
0.001), and was particularly common among those
taking compound codeine tablets (5 out of 10).
Patients not only smoked more frequently than con-
trols (X2 = 5.2; P <0.05), but were also more prone
to smoke more than 20 cigarettes a day (X2 = 10.9; P
<0.001).
Dependence on analgesics. Thus, patients with
analgesic nephropathy take analgesics for inappro-
priate reasons. Drug abuse is defined [35] as "the
consumption of a drug apart from medical need or in
unnecessary quantities," and clearly my patients'
use of analgesics falls into this category. These
patients seldom volunteered information about their
drug habits, and in many cases persistently denied
analgesic abuse. Assessment of analgesic consump-
tion, therefore, required an oblique approach via
headaches or other symptoms, and frequently fur-
ther evidence had to be sought from relatives. Fur-
thermore, for at least 20 of the patients, knowledge
of the consequences of analgesic abuse was no deter-
rent to continued consumption.
Thus, these patients exhibited many of the fea-
tures of drug dependence, and, indeed, several phy-
sicians have remarked that they believed their
patients were habituated or addicted [26, 28, 30, 36—
381. Although the World Health Organisation Expert
Committee [39] did not consider the possibility of
dependence on minor analgesics, Wilson [40] has
described this and has suggested that it is associated
with psychic dependence, psychotoxicity, and possi-
bly tolerance.
My patients undoubtedly showed psychic depen-
dence in that they had "a psychic drive for continu-
ous . . . administration of the drug" [41]. Most had
begun taking the analgesic for pain, but the depen-
dence resulted from appreciation of effects other
than the analgesic action. The amounts of caffeine
which the patients were taking would have a marked
stimulating effect [42], and Driesbach and Pfeiffer
[43] have shown that the caffeine withdrawal head-
ache, by causing further analgesic consumption, pro-
vides "a plausible explanation for the hitherto empir-
ical addition of caffeine to many headache
mixtures." In addition, phenacetin has mild anxioly-
tic properties [44—46] and many people find it plea-
surable [45], while the dependence-producing quali-
ties of codeine are well known [47]. Thus, the
patients' dependence can be largely attributed to the
psychoactivity of the analgesic mixtures, in which
the psychotropic effects of the constituents are
potentiated [45, 48, 49]. Nevertheless, one must also
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consider the role of the extensive advertising of pro-
prietary analgesics for neurotic complaints in rein-
forcing the dependence.
There was, too, a tendency to increase the dose
taken, which was augmented by symptoms of anal-
gesic intoxication, caffeine withdrawal, and eventu-
ally uremia. Thus, the drugs were taken for symp-
toms which they themselves had caused, and a
vicious circle of decreasing health and increasing
intake of analgesics was set up.
Several authors 1129, 50] have noted the familial
occurrence of analgesic nephropathy. That 43 per-
cent of my patients had a relative who also abused
analgesics suggests that the disorder stems from
abnormal attitudes to analgesics which are often fam-
ily transmitted, particularly by mothers introducing
their children to excessive analgesic taking.
The patients had often suffered parental depriva-
tion or unhappy childhoods, and although they did
not have the high divorce rate which others have
noted [27, 37], over half were unhappily married.
Sexual difficulties and heavy drinking by husbands
were major causes of marital discord. Among single
women, two-thirds of whom were socially isolated,
loneliness was an important factor. Stressfull events
were often important in starting and perpetuating
analgesic abuse.
The majority of my patients showed evidence of
either personality disorder of an inadequate nature or
proneness to neurotic breakdown. To my knowl-
edge, there has been only one previous study of
psychosocial factors in analgesic nephropathy 1130],
but many physicians have commented on the fre-
quency of psychiatric disorder in their patients. In
particular, Gault et al [271 noted "emotional instabil-
ity of an immature and dependent nature," while
Gsell, Dubach, and Raillard-Peucker [51] believed
that "a depressive syndrome and temperamental
instability were the most common expressions," and
Whitlock and Lowrey [521 concluded that analgesic
abusers often "showed features of personality
disorder."
My patients' frequent previous hospital atten-
dances and their unnecessary gynecological investi-
gations were a reflection of their hypochondriacal
and pain-prone personalities, and their tendency,
possibly because of limited intelligence, to somatize
emotional conflict. Because of the frequency of
attempted suicide, there have been suggestions that
patients with analgesic nephropathy wish to harm
themselves. This seems unlikely, as before their ini-
tial presentation they were seldom aware of the dan-
gers of analgesic abuse. The frequency of alcoholism
[25, 30, 51, 531, abuse of other drugs [25, 31, 51], and
excessive smoking [25, 31, 371 has been previously
noted; in addition, my patients often abused purga-
tives. There can therefore be little doubt that they
were dependence-prone.
Predisposing personality factors
In an effort to further define the predisposing fac-
tors, I administered the Eysenck Personality Inven-
tory (EPI) to 45 of the patients [541. This is a 57-item
questionnaire designed to measure neuroticism (N)
and extraversion-introversion (F), and also contains
a short lie scale (L). The reliability and validity of
these scales is well established [55].
The EPI was also administered to two control
groups. The first consisted of 33 patients consecu-
tively seen at the renal unit with renal disease of
severity comparable with those with analgesic
nephropathy but not due to analgesic abuse. The
second control group consisted of 20 patients, seen
by the author, who abused analgesics but who did
not have renal disease.
Of the 45 patients, 30 scored as introverted and
neurotic, six as extraverted and neurotic, five as
introverted and stable, and four as extraverted and
stable. The mean E score SD of the patients was
9.07 3.89 compared with an expected 12.07 4.37
for normals. The mean N score SD of the patients
was 14.49 5.52, as against an expected 9.07 4.78.
The renal controls were more extraverted and less
neurotic than the patients. The differences in both E
and N were fairly significant (P < 0.05). The 20
analgesic controls were significantly more introvert-
ed than the patients (P <0.01). They also tended to
be more neurotic, but this difference failed to reach
significance. L scores of the control groups were
similar to those of the patients.
Patients with analgesic nephropathy appear highly
introverted and neurotic. Have these traits contribut-
ed to their analgesic abuse or are they merely the
consequence of their illness? There are two possible
reasons why the latter might be the case. First, these
patients suffer from a chronic illness which restricts
their lives and requires regular medical supervision.
This might increase introversion and neuroticism.
Second, uremia might, by a direct cerebral effect,
exaggerate these traits.
One can exclude the second possibility, as there
was no relation between the EPI scores of either the
patients or the renal controls and uremia. If low E
and high N were the result of chronic illness, the
renal controls ought to have had similar scores. But,
although the latter were mildly introverted and neu-
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rotic, they were significantly less so than the
patients. Thus, it seems that chronic renal disease
does have some effect on E and N, hut this is insuffi-
cient to account for the scores of the patients with
analgesic nephropathy.
Furthermore, analgesic abusers without renal
impairment showed low E and high N scores.
Increased introversion and neuroticism must, there-
fore, be related to analgesic abuse as either its cause
or result. It is theoretically possible that analgesic
abuse might cause symptoms which could influence
an individual completing the EPI to score certain
items positively. None of the usual manifestations of
analgesic ingestion or intoxication, however, would
interfere in this way, so this explanation appears
unlikely.
An individual's experience of pain and his reaction
to it is influenced by a wide range of factors including
his personality. Eysenck [56] has shown that intro-
verts have lower pain thresholds than extraverts,
while Bond [57] noted that subjects with high N
tolerate pain badly. Thus, introverted neurotics
would not only experience pain as more severe than
normals, but they would be less able to tolerate it.
They would, therefore, have a strong incentive to
take analgesics.
Bond believes that complaint behavior is related to
extraversion-introversion, and that extraverts com-
municate their symptoms freely while introverts tend
to be "non-complainers." He has shown that intro-
verts with pain are less likely to ask nursing staff for
analgesics than extraverts. Thus, introverted neurot-
ics such as these patients would be reluctant to seek
analgesics from their doctors, and might instead
resort to self-medication.
Introverts develop conditioned reflexes more easi-
ly than extraverts t1561, and would, therefore, more
readily associate the pleasurable mood-altering
effects of compound analgesics with the act of anal-
gesic-taking. They would become conditioned to the
regular taking of analgesics more quickly, and high N
would provide the drive to continue reinforcing the
analgesic ingestion. In short, subjects with the per-
sonality traits shown by the patients with analgesic
nephropathy would be most likely to prescribe them-
selves regular analgesics and to persist until they
became dependent on the drugs.
Summary
Analgesic nephropathy is more common in West-
ern Scotland than elsewhere in the United Kingdom.
This appears to be a consequence of the frequency
with which local people take Askit®, a preparation
different from most other British analgesics in that
they contain more caffeine and in their presentation
as powders. Surveys of different populations in Glas-
gow suggest that while aspirin and paracetamol tend
to be taken relatively infrequently and for appropri-
ate reasons such as pain, Askit® is more likely to be
taken with excessive frequency for its supposed
mood-altering properties. Working-class women
with psychiatric problems are especially prone to
daily self-medication.
Study of individuals with analgesic nephropathy
reveals that in Westem Scotland, at least, the cause
is dependence on analgesics. The characteristics of
this include a need to continue taking and to slowly
increase the dose of analgesics, partly owing to toler-
ance and partly to treat symptoms the analgesic
ingestion has caused, as well as a psychic depen-
dence resulting from appreciation of the psychotrop-
ic effects of the compound analgesics. When com-
pared with matched controls, those who develop the
"analgesic abuse syndrome" are more likely to have
a family history of analgesic abuse, alcoholism, and
psychiatric disorder. They tend to be introverted and
neurotic, are prone to abuse other drugs and many
have had previous psychiatric treatment.
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